BEZ235 对甲苯磺酸盐 | 1028385-32-1

• 物质功能分类: 生物化工 - 生化试剂 - 激动剂抑制剂
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: BEZ235 对甲苯磺酸盐
• 中文别名: BEZ235对甲苯磺酸盐
• 英文名称: 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate salt
• 英文别名: BEZ235 monotosylate；NVP-BEZ235 tosylate；2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate；2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]propionitrile p-toluenesulfonate；Dactolisib Tosylate；4-methylbenzenesulfonic acid;2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile
• CAS: 1028385-32-1
• 化学式: C₇H₈O₃S*C₃₀H₂₃N₅O
• 分子量: 641.75
• InChiKey: FWURTHAUPVXZHW-UHFFFAOYSA-N

物化性质

• 溶解度：
  溶于二甲基亚砜

计算性质

• 辛醇/水分配系数(LogP)：
  7.14
• 重原子数：
  47
• 可旋转键数：
  4
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  136
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  BEZ235 对甲苯磺酸盐 以 乙醇 、 丙酮 为溶剂， 生成 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]propionitrile p-toluenesulfonate monohydrate
  参考文献：
  名称：

  WO2008/64093

  摘要：

  公开号：
• 作为产物：
  描述：

  2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile 、 对甲苯磺酸 在 甲酸 作用下， 以 丙酮 为溶剂， 反应 5.5h， 以82.4%的产率得到BEZ235 对甲苯磺酸盐
  参考文献：
  名称：

  WO2008/64093

  摘要：

  公开号：

文献信息

• 1,3-Dihydro-Imidazo [4,5-C] Quinolin-2-Ones as Lipid Kinase Inhibitors
  申请人：Garcia-Echeverria Carlos

  公开号：US20080194579A1

  公开（公告）日：2008-08-14

  The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.

  本发明涉及公式（I）的新有机化合物，其制备方法，其在治疗人体或动物的过程中的应用，其单独或与一种或多种其他药物活性化合物结合使用，用于治疗炎症或阻塞性呼吸道疾病，如哮喘，与移植相关的常见疾病或增生性疾病，如肿瘤疾病。
• 1,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS
  申请人：Garcia-Echeverria Carlos

  公开号：US20100056558A1

  公开（公告）日：2010-03-04

  The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.

  本发明涉及公式（I）的新有机化合物，其制备方法，其在处理人或动物体的过程中的应用，其单独使用或与一个或多个其他药物活性化合物结合使用，用于治疗炎症或阻塞性呼吸道疾病，如哮喘，与移植有关的常见疾病或增生性疾病，如肿瘤疾病。
• Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
  申请人：Stowasser Frank

  公开号：US20100168153A1

  公开（公告）日：2010-07-01

  The invention relates to particular crystalline forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile, its hydrates and solvates, its salts and hydrates and solvates of its salts, certain processes for their preparation, pharmaceutical compositions containing these crystalline forms, and their use in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans.

  本发明涉及2-甲基-2-[4-(3-甲基-2-氧代-8-喹啉-3-基-2,3-二氢咪唑[4,5-c]喹啉-1-基)-苯基]-丙腈的特定晶体形式、其水合物和溶剂化合物、其盐及其盐的水合物和溶剂化合物，以及制备这些晶体形式的某些方法、含有这些晶体形式的制药组合物，以及其用于诊断方法或更好地用于治疗恒温动物，特别是人类，以及其用作中间体或用于制备用于诊断方法或更好地用于治疗恒温动物，特别是人类的制药制剂。
• Imidazoquinolines as lipid kinase inhibitors
  申请人：Garcia-Echeverria Carlos

  公开号：US20120207751A1

  公开（公告）日：2012-08-16

  The invention relates to a combination comprising compounds of formula (I) and one or more other antiproliferative compounds, hormones or radiation, pharmaceutical preparations comprising the combination thereof, and the application thereof in a process for the treatment of tumors.

  本发明涉及一种组合物，包括式(I)的化合物和一种或多种其他抗增殖化合物、激素或辐射，以及包含该组合物的药物制剂，以及其在肿瘤治疗过程中的应用。
• 1,3-Dihydro-imidazo[4,5-c]quinolin-2-ones as Lipid Kinase Inhibitors
  申请人：GARCIA-ECHEVERRIA Carlos

  公开号：US20110251202A1

  公开（公告）日：2011-10-13

  The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.

  本发明涉及式(I)的新型有机化合物，其制备方法，其在用于治疗人或动物体内的过程中的应用，其使用-单独或与一种或多种其他药物活性化合物结合使用-用于治疗炎症性或阻塞性呼吸道疾病，如哮喘，与移植有关的常见疾病或增殖性疾病，如肿瘤疾病。